Affordable Access

Intraperitoneal radioactive phosphate in early ovarian carcinoma: an analysis of complications.

Authors
Type
Published Article
Journal
International Journal of Radiation Oncology*Biology*Physics
0360-3016
Publisher
Elsevier
Publication Date
Volume
20
Issue
5
Pages
939–944
Identifiers
PMID: 2022522
Source
Medline
License
Unknown

Abstract

Intraperitoneal radioactive chromic phosphate was administered to 69 patients with Stage I and II ovarian carcinoma who had undergone comprehensive surgical staging. Intestinal obstruction requiring surgical intervention occurred in four patients and was the most severe complication. Abdominal pain was the most common post-therapy complaint. Attention to time and technique of drug administration could minimize complications.

Statistics

Seen <100 times